Bacteria in the gut may reveal Parkinson's risk years before symptoms appear
Long before a tremor appears or a step falters, the trillions of microorganisms living in the human gut may already be composing a warning. Researchers at University College London have found that distinctive bacterial patterns in the gut can identify Parkinson's disease risk years ahead of any neurological symptom — even in people who carry a genetic predisposition but feel entirely well. Published in Nature Medicine, the discovery suggests that the boundary between prevention and treatment may be redrawn, and that the path to protecting the brain might begin, quietly, in the belly.
- Parkinson's is the world's fastest-growing neurodegenerative disease, yet it remains nearly invisible until significant neurological damage has already occurred — making early detection not just useful, but urgent.
- A study of over 500 participants revealed that 176 gut microbial species shift in measurable ways across the spectrum from healthy to genetically at-risk to fully diagnosed, suggesting the gut is narrating a story the brain has not yet told.
- Healthy individuals whose microbiomes resembled the high-risk profile introduce a troubling uncertainty: does a dangerous gut signature seal one's fate, or do diet, genetics, and environment still hold the deciding vote?
- Dietary quality emerged as a potential shield — participants eating more balanced, varied meals were less likely to carry the high-risk microbial signature, pointing toward a surprisingly accessible form of prevention.
- UCL teams are now running the world's largest clinical trial to slow Parkinson's progression and testing whether a common cough medicine can help those with genetic risk, placing this microbiome discovery at the leading edge of a rapidly accelerating field.
Researchers at University College London have found that the bacteria living in the human gut may signal Parkinson's disease risk years before any symptom emerges. The study, published in Nature Medicine, analyzed fecal samples from people already diagnosed with Parkinson's, asymptomatic carriers of the high-risk GBA1 gene variant, and healthy controls — and found that more than a quarter of all gut microbial species showed distinctly different patterns across these groups.
The most consequential finding was that people carrying the GBA1 variant, though entirely symptom-free, already displayed microbial shifts that fell between healthy and diseased profiles. This suggests the gut is registering biological change long before the brain makes it visible. Professor Anthony Schapira, who led the research, noted that identifying at-risk individuals before symptoms appear is essential if future treatments are ever to slow or prevent the disease rather than merely manage it.
The findings were validated across an additional 957 participants in the UK, Korea, and Turkey. A small number of healthy controls also showed high-risk microbiome patterns — raising the question of whether other factors determine whether disease actually develops. One clue emerged from dietary data: participants who ate more balanced, varied diets were less likely to carry the worrying microbial signature, hinting that food choices may influence whether gut bacteria steer a person toward neurological decline.
The discovery fits into a broader and accelerating picture of gut-brain connection. UCL researchers have separately shown that Parkinson's may spread from gut to brain via immune cells, and the institution is currently running the world's largest trial aimed at slowing disease progression. For now, the microbiome findings offer something both modest and profound — a potential early warning system, and the suggestion that prevention might begin not in a clinic, but at the dinner table.
Researchers at University College London have discovered that the bacteria living in your gut may hold clues to whether you'll develop Parkinson's disease—years before you ever feel a tremor or notice your movements slowing. The finding, published in Nature Medicine, suggests that a simple analysis of fecal samples could one day serve as an early warning system for a disease that affects millions worldwide and is growing faster than any other neurodegenerative condition.
The study examined gut microbiomes from three groups: 271 people already diagnosed with Parkinson's, 43 people carrying a genetic variant called GBA1 that dramatically increases disease risk but who showed no symptoms yet, and 150 healthy control participants. What the researchers found was striking: over a quarter of the microbial species in the gut—176 different types of bacteria—showed distinctly different patterns depending on which group a person belonged to. Some bacteria flourished in Parkinson's patients while others dominated in healthy individuals. The pattern was most pronounced in people with more advanced disease, but the crucial discovery was that people carrying the GBA1 gene variant without any symptoms already displayed these same microbial shifts, just in an intermediate form between the healthy and diseased groups.
Professor Anthony Schapira, who led the work, emphasized the urgency of the moment. Parkinson's remains a major cause of disability globally, and treatments that can actually slow or stop its progression remain elusive. To use such treatments effectively, doctors need to identify people at risk long before symptoms emerge. "For the first time we identify bacteria in the gut of people with Parkinson's that can also be found in those with a genetic risk for the disease, but before they develop symptoms," Schapira said. The implications extend beyond diagnosis: if these bacterial changes are driving disease risk rather than merely reflecting it, then altering the microbiome through diet or medication might prevent Parkinson's from developing in the first place.
The team validated their findings by analyzing data from an additional 638 Parkinson's patients and 319 healthy controls across the UK, Korea, and Turkey. Intriguingly, a small proportion of the healthy control group also showed microbiome patterns associated with Parkinson's risk, raising an unsettling question: are these people destined to develop the disease, or do other genetic and environmental factors determine whether someone actually gets sick? The researchers found one potential answer in dietary data. Participants who ate more balanced and varied diets were less likely to have the high-risk microbiome signature, suggesting that what you eat may influence whether your gut bacteria put you on a path toward neurological decline.
The work builds on a growing body of evidence linking gut health to brain disease. Recent UCL research has shown how Parkinson's may actually spread from the gut to the brain with help from immune cells—a discovery that opens new avenues for treatment. The field is moving quickly. UCL researchers are currently running the world's largest clinical trial testing treatments to slow or stop Parkinson's progression, and they're also testing whether a common cough medicine might help people with genetic risk factors. For now, the microbiome findings offer something more modest but potentially profound: a way to identify who needs help before the disease takes hold, and a hint that the answer might be as simple as what's on your plate.
Citas Notables
For the first time we identify bacteria in the gut of people with Parkinson's that can also be found in those with a genetic risk for the disease, but before they develop symptoms.— Professor Anthony Schapira, UCL Queen Square Institute of Neurology
Gut microbiome analysis can enable us to identify individuals who are at risk of developing Parkinson's disease, so that we can suggest ways for them to reduce their own risk, such as through dietary adjustments.— Professor Stanislav Dusko Ehrlich, UCL Queen Square Institute of Neurology
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that asymptomatic carriers have the same bacterial patterns as people with actual Parkinson's?
Because it suggests the microbiome changes aren't just a consequence of having the disease—they might be part of what causes it. If we can catch those changes before symptoms appear, we might be able to intervene.
But you said some healthy people also had these patterns. Doesn't that complicate things?
It does. It means the microbiome is necessary but not sufficient. Something else—genetics, environment, maybe luck—determines whether someone with these bacterial patterns actually develops Parkinson's.
The diet finding seems almost too simple. Can changing what you eat really prevent a neurodegenerative disease?
The study shows correlation, not causation yet. But it's plausible. Your diet shapes which bacteria thrive in your gut. If certain bacteria protect you or certain ones harm you, then yes, diet could matter enormously.
What happens next? Do people get tested?
Not yet. This is foundational work. They need to understand whether these bacteria are drivers or passengers, and whether changing the microbiome actually prevents disease. That takes years of follow-up.
So for someone with the GBA1 gene right now, what should they do?
The honest answer is we don't know yet. But the researchers are suggesting people pay attention to diet quality—eat varied, balanced meals. It might help. It certainly won't hurt.